Analyst Reco. Enanta Pharmaceuticals, Inc.

Equities

ENTA

US29251M1062

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-10 pm EDT			5-day change	1st Jan Change
12.78 ^USD	-1.01%		+3.23%	+35.81%

May. 07	JMP Securities Adjusts Enanta Pharmaceuticals Price Target to $22 From $23, Maintains Market Outperform Rating	MT
May. 06	Transcript : Enanta Pharmaceuticals, Inc., Q2 2024 Earnings Call, May 06, 2024

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JMP Securities Adjusts Enanta Pharmaceuticals Price Target to $22 From $23, Maintains Market Outperform Rating	May. 07	MT
Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $17 From $21, Maintains Perform Rating	Feb. 09	MT
Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $21 From $25, Maintains Perform Rating	Nov. 22	MT
HC Wainwright Cuts Enanta Pharmaceuticals' Price Target to $28 From $30, Maintains Buy Rating	Nov. 21	MT
HC Wainwright Adjusts Enanta Pharmaceuticals Price Target to $30 From $48, Maintains Buy Rating	23-10-23	MT
Enanta Pharmaceuticals Receives Speculative Risk Qualifier on Sector Perform Rating From RBC, Price Target Cut to $15 From $25	23-10-02	MT
Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $25 From $30, Maintains Perform Rating	23-08-09	MT
JMP Securities Lowers Price Target on Enanta Pharmaceuticals to $42 From $65, Maintains Market Outperform Rating	23-08-08	MT
Jefferies Downgrades Enanta Pharmaceuticals to Hold From Buy, Adjusts Price Target to $18 From $49	23-08-08	MT
RBC Cuts Enanta Pharmaceuticals' Price Target to $25 From $33, Keeps Sector Perform Rating	23-07-07	MT
Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $30 From $50, Maintains Perform Rating	23-05-11	MT
JMP Securities Adjusts Price Target on Enanta Pharmaceuticals to $65 From $82, Keeps Market Outperform Rating	23-05-09	MT
HC Wainwright Adjusts Enanta Pharmaceuticals' Price Target to $48 From $68, Keeps Buy Rating	23-05-09	MT
JMP Securities Adjusts Enanta Pharmaceuticals' Price Target to $65 From $82, Keeps Market Outperform Rating	23-05-09	MT
RBC Cuts Price Target on Enanta Pharmaceuticals to $33 From $48, Maintains Sector Perform Rating	23-05-09	MT
RBC Capital Adjusts Enanta Pharmaceuticals Price Target to $48 From $54, Maintains Sector Perform Rating	23-04-06	MT
RBC Lifts Price Target on Enanta Pharmaceuticals to $54 From $52, Maintains Sector Perform Rating	23-02-28	MT
JPMorgan Adjusts Enanta Pharmaceuticals Price Target to $60 From $74, Maintains Neutral Rating	23-02-08	MT
RBC Raises Enanta Pharmaceuticals' Price Target $52 From $49, Maintains Sector Perform Rating	23-02-08	MT
SVB Securities Adjusts Enanta Pharmaceuticals' Price Target to $49 From $50, Keeps Market Perform Rating	23-01-27	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Enanta Pharmaceuticals, Inc.

Equities

ENTA

US29251M1062

Analyst Reco.

Filters